FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 5, 2020

Results 101 through 150 of 217

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
HRTX Nasdaq Heron Therapeutics Inc 2834
HSTO Nasdaq Histogen Inc 2834
HTBX Nasdaq Heat Biologics Inc 2834
HZNP Nasdaq Horizon Therapeutics PLC 2834
ICPT Nasdaq Intercept Pharmaceuticals Inc 2834
IMAB Nasdaq I-Mab ADR 2834
IMUN Over the counter Immune Therapeutics Inc 2834
INBP Over the counter Integrated BioPharma, Inc. 2834
INFI Nasdaq Infinity Pharmaceuticals Inc. 2834
INSM Nasdaq Insmed Incorporated 2834
INVA Nasdaq Innoviva Inc 2834
IPIX Over the counter Innovation Pharmaceuticals Inc 2834
JAGX Nasdaq Jaguar Health Inc 2834
JAZZ Nasdaq Jazz Pharmaceuticals PLC 2834
JNJ New York Johnson & Johnson 2834
KALA Nasdaq Kala Pharmaceuticals Inc 2834
KDMN New York Kadmon Holdings Inc 2834
LCI New York Lannett Company, Inc. 2834
LFVN Nasdaq LifeVantage Corp 2834
LIFE Nasdaq aTyr Pharma Inc 2834
LLY New York Eli Lilly And Co 2834
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2834
MBRX Nasdaq Moleculin Biotech Inc 2834
MDGL Nasdaq Madrigal Pharmaceuticals Inc 2834
MDWD Nasdaq Mediwound Ltd 2834
MEIP Nasdaq MEI Pharma Inc 2834
MGNX Nasdaq MacroGenics Inc 2834
MNK New York Mallinckrodt PLC 2834
MNKD Nasdaq MannKind Corporation 2834
MORF Nasdaq Morphic Holding Inc 2834
MRK New York Merck & Co., Inc. 2834
MRNS Nasdaq Marinus Pharmaceuticals Inc 2834
MYGN Nasdaq Myriad Genetics, Inc. 2834
MYL Nasdaq Mylan NV 2834
NEOS Nasdaq Neos Therapeutics Inc 2834
NERV Nasdaq Minerva Neurosciences Inc 2834
NGM Nasdaq NGM Biopharmaceuticals Inc 2834
NOVN Nasdaq Novan Inc 2834
NTRB Over the counter Nutriband Inc 2834
NTRR Over the counter Neutra Corp 2834
NVO New York Novo Nordisk A/S (ADR) 2834
NVS New York Novartis AG (ADR) 2834
NVUS Nasdaq Novus Therapeutics Inc 2834
NXEN Over the counter Nexien Biopharma Inc 2834
ODT Nasdaq Odonate Therapeutics Inc 2834
OMER Nasdaq Omeros Corporation 2834
ONTX Nasdaq Onconova Therapeutics Inc 2834
OPK Nasdaq Opko Health Inc. 2834
OPTN Nasdaq OptiNose Inc 2834
ORGO Nasdaq Organogenesis Holdings Inc 2834
Results 100 through 150 of 217